At Philo, we’re a group of technology and product people who set out to build the future of television, marrying the best in modern technology with the most compelling medium ever invented — in short, we’re
Nouscom is a private clinical stage immuno-oncology company developing next-generation, off-the-shelf and personalized cancer vaccines. Our proprietary viral vector platform has the capacity to encode for large payloads of neoantigens or other immunomodulators and is clinically demonstrated